Phi Pharma
Sion
About Phi Pharma
Phi Pharma is a private Swiss-based biopharmaceutical company. It specializes in the discovery and early clinical development of drug conjugates for improving treatment of diseases with high-medical need. Phi Pharma technology allows development of a powerful new class of peptide drug conjugates through specific cellular targeting and efficient intra-cellular delivery. Company programs are in oncology and infectious diseases.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $3.6M
- Funding stage: Early Stage Venture
- Last round: Series A (Dec 2016)
- Website: phi-pharma.com
- Phone: [email protected]
Industries & Categories
Biopharma, Biotechnology, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/phi-pharma-183843 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.